Brady COO DeBruine Sells 1,569 Shares of Company Stock
Brady Corp's COO, Thomas F. DeBruine, sold 1,569 shares of Class A common stock, reflecting changes in executive stock holdings.
Bailo Karen Reports Restricted Stock Units Transaction
Bailo Karen, President at Progressive Corp, disclosed a transaction of restricted stock units, highlighting executive compensation trends in the insurance industry.
Wertz Gwendolyn reports stock acquisition in Provident Holdings
Wertz Gwendolyn discloses a stock acquisition in Provident Financial Holdings, reflecting ongoing trends in employee equity participation in the finance sector.
Japan Post Holdings sells 13,000 shares of Aflac Inc.
Japan Post Holdings Co., Ltd. reports sale of 13,000 shares of Aflac Inc., reflecting strategic investment management and potential industry impacts.
Wertz Gwendolyn Reports Stock Transaction at Provident Financial
Wertz Gwendolyn, Senior VP at Provident Financial, reports stock transaction of 686 shares, reflecting confidence in the savings institution's future.
Star Bulk Carriers director sells 6,000 shares in transaction
Star Bulk Carriers Corp. director Erhardt Koert sells 6,000 shares at $30.39 each, reflecting ownership adjustments in the deep sea transportation sector.
MacDonald Ryan S acquires 6,700 shares in Bluerock Fund
Ryan S. MacDonald reports acquisition of 6,700 shares in Bluerock Private Real Estate Fund, indicating confidence in the real estate investment sector.
Provident Financial CEO Ternes Reports Stock Transaction
Donovan P. Ternes, CEO of Provident Financial, reports a stock transaction in recent SEC filing, reflecting commitment to the company and industry trends.
Fitzgerald reports acquisition of 21,517 shares in Middleby
Timothy John Fitzgerald acquires 21,517 shares of Middleby Corp, indicating confidence in the company's future within the refrigeration machinery sector.
AgomAb Therapeutics director acquires 10,000 shares
David R. Epstein, a director at AgomAb Therapeutics, acquires 10,000 shares in recent transactions, signaling confidence in the company's future.
Carvana CEO Garcia Reports Stock Transaction in SEC Filing
Ernest C. Garcia III, CEO of Carvana Co., reports a stock transaction involving 7,067 shares in recent SEC filing, highlighting ongoing financial activities.
F&G Annuities Director Acquires Common Stock in Transaction
F&G Annuities & Life, Inc. reports stock acquisition by director, signaling alignment of executive interests with shareholder value.
Blevins acquires 12,000 RSUs, boosting stake in Quantum Corp
Tony J. Blevins increases his stake in Quantum Corp by acquiring 12,000 restricted stock units, reflecting his ongoing commitment to the company.
Demetriou reports phantom stock acquisition at FirstEnergy
Steven J. Demetriou acquires phantom stock units at FirstEnergy Corp., reflecting ongoing compensation strategies in the electric services sector.
Designer Brands director reports stock unit transaction
Designer Brands Inc. director Allan J. Tanenbaum reported a stock unit transaction, reflecting ongoing activity in the retail shoe store sector.
Ritter Robert Scott reports stock transaction for Provident
Ritter Robert Scott, Senior VP of Provident Financial, reported a stock transaction involving 1,843 shares, emphasizing transparency in executive stock dealings.
Park Meroe Sunhee Acquires Additional Shares in Bank of N.T. Butterfield
Park Meroe Sunhee increases stake in Bank of N.T. Butterfield by acquiring 1,052 shares, signaling confidence in the commercial banking sector.
Veeva Systems EVP Daniel Rizzo Reports Stock Transactions
Daniel Rizzo of Veeva Systems disclosed multiple stock transactions, indicating active equity management amid the prepackaged software sector.
Burgoyne Reports Significant Stock Acquisitions at Vail Resorts
Celeste Burgoyne of Vail Resorts reports major stock acquisitions, reflecting a strategic focus on executive compensation and alignment with shareholder interests.
Marks Gilbert Lynn Acquires Additional Shares in AN2 Therapeutics
Marks Gilbert Lynn increases his stake in AN2 Therapeutics by acquiring 2,283 shares, signaling confidence in the pharmaceutical sector's growth.